Home › Brain Diseases › Texas › Houston
Brain Diseases clinical trials in Houston, TX
7 studies for Brain Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center at Houston, Houston
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecruitingPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Study of Selected X-Linked Disorders: Aicardi Syndrome
RecruitingObservational study
- Baylor College of Medicine, Houston
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
RecruitingObservational studyHealthy volunteers welcome
- Baylor College of Medicine, Houston
Open-label Extension Study in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- GSK Investigational Site, Houston
About Brain Diseases
Brain diseases affect different functions of the body from memory, speech, thinking clearly, how well the different organs work, or even movement.
More about Brain Diseases on MedlinePlus
Brain Diseases trials in other cities
- Boston, MA7 studies
- Orlando, FL7 studies
- New York City, NY7 studies
- St. Louis, MO7 studies
- Miami, FL6 studies
- Pittsburgh, PA6 studies
- Washington, DC6 studies
- San Diego, CA5 studies
- Philadelphia, PA5 studies
- West Palm Beach, FL4 studies
- Dallas, TX4 studies
- Akron, OH4 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.